A Compact, High-Accuracy Cas9 with a Dinucleotide PAM for In Vivo Genome Editing

Cited by (265)

Items 101–200 of 265

  1. High-fidelity KKH variant of Staphylococcus aureus Cas9 nucleases with improved base mismatch discrimination
    Chaya T. L. Yuen, Dawn Thean, Becky K.C. Chan, Peng Zhou, Cynthia C. S. Kwok, Hoi Yee Chu, Maggie S.H. Cheung, Bei Wang, Yee Man Chan, Silvia Y. L. Mak et al. · 2021 · Nucleic Acids Research
  2. Targeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery
    Jiyeon Kweon, An-Hee Jang, Eun‐Ji Kwon, Un Gi Kim, Ha Rim Shin, Ji-Eun See, Gayoung Jang, Chaeyeon Lee, Taeyoung Koo, Seokjoong Kim et al. · 2023 · Experimental & Molecular Medicine
  3. Genome Editing Technology: A New Frontier for the Treatment and Prevention of Cardiovascular Diseases
    Sumbul Saeed, Shahid Ullah Khan, Wasim Ullah Khan, Mostafa A. Abdel-Maksoud, Ayman Mubarak, Mohammed Aufy, Faisal Ayub Kiani, Abdul Wahab, Muhammad Wajid Shah, Muhammad Wajid Shah · 2023 · Current Problems in Cardiology
  4. Massively parallel evaluation and computational prediction of the activities and specificities of 17 small Cas9s
    Sang-Yeon Seo, Seonwoo Min, Sungtae Lee, Jung Hwa Seo, Jinman Park, Hui Kwon Kim, Myungjae Song, Dawoon Baek, Sung‐Rae Cho, Seokjoong Kim · 2023 · Nature Methods
  5. A systematic review of computational methods for designing efficient guides for CRISPR DNA base editor systems
    Göknur Giner, Saima Ikram, Marco J. Herold, Anthony T. Papenfuss · 2023 · Briefings in Bioinformatics
  6. Phage-assisted evolution of compact Cas9 variants targeting a simple NNG PAM
    Tao Qi, Yao Wang, Yuan Yang, Siqi Gao, Jingtong Liu, Qiang Huang, Yuwen Tian, Junnan Tang, Wei Zheng, Yongming Wang · 2023 · Nature Chemical Biology
  7. Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for Mammalian Genome Editing
    Ning Gao, Chengdong Zhang, Ziying Hu, Miaomiao Li, Jingjing Wei, Yongming Wang, Huihui Liu · 2020 · Frontiers in Cell and Developmental Biology
  8. CRISPR Systems Suitable for Single AAV Vector Delivery
    Marta Stevanovic, Elena Piotter, Michelle E. McClements, Robert Edward MacLaren · 2021 · Current Gene Therapy
  9. Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
    Leyao Li, Lakshmy Vasan, Bryan Kartono, Kevan P. Clifford, Ahmadreza Attarpour, Raghav Sharma, Matthew Mandrozos, Ain Kim, Wenda Zhao, Ari Belotserkovsky et al. · 2023 · Biomedicines
  10. Genome-wide detection and analysis of CRISPR-Cas off-targets
    Tomás Rodríguez, Sina Dadafarin, Henry Pratt, Pengpeng Liu, Nadia Amrani, Lihua Julie Zhu · 2021 · Progress in molecular biology and translational science
  11. High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
    Yuan Wu, Yu‐Lan Xiao, Weixin Tang · 2025 · Nature Biotechnology
  12. Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition
    Shuai Wang, Chen Tao, Huilin Mao, Linghui Hou, Yao Wang, Tao Qi, Yuan Yang, Sang‐Ging Ong, Shijun Hu, Renjie Chai et al. · 2022 · PLoS Biology
  13. New Biological Therapies for Low-Density Lipoprotein Cholesterol
    Praneet K. Gill, Robert Alexander Hegele · 2023 · Canadian Journal of Cardiology
  14. Reprogramming an RNA-guided archaeal TnpB endonuclease for genome editing
    Ying Cao Xu, Tao Liu, Jing Wang, Binyang Xiong, Ling Liu, Nan Peng · 2023 · Cell Discovery
  15. CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
    Shahin Eghbalsaied, Clancy Lawler, Björn Petersen, Raul A. Hajiyev, Steve R. Bischoff, Stephen Frankenberg · 2024 · Gene Therapy
  16. Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
    Cia‐Hin Lau, Qingle Liang, Haibao Zhu · 2024 · Transgenic Research
  17. Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles
    Dmitrii Degtev, Jack P. K. Bravo, Aikaterini Emmanouilidi, Aleksandar Zdravković, Oi Kuan Choong, Julia Liz Touza, Niklas Selfjord, Isabel Weisheit, Margherita Francescatto, Pınar Akçakaya et al. · 2024 · Nature Communications
  18. Genome editing technologies to treat rare liver diseases
    Marta Trevisan, Giulia Masi, Giorgio Palù · 2020 · Translational Gastroenterology and Hepatology
  19. Genome and transcriptome engineering by compact and versatile CRISPR-Cas systems
    Guillermo Aquino‐Jarquín · 2023 · Drug Discovery Today
  20. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research
    Prashant K. Pandey, Teagen D. Quilichini, Neha Vaid, Peng Gao, Daoquan Xiang, Raju Datla · 2019 · Seminars in Cell and Developmental Biology
  21. Liver-directed gene-based therapies for inborn errors of metabolism
    Pasquale Piccolo, Alessandro Rossi, Nicola Brunetti‐Pierri · 2020 · Expert Opinion on Biological Therapy
  22. CrisPR/CRIS systems are highly effective and useful for genomic manipulation. Despite this, cardiac treatment remains difficult due to existing genome editing and delivery processes.
    Moataz Dowaidar · 2021 · OSF Preprints (OSF Preprints)
  23. Genome editing with natural and engineered CjCas9 orthologs
    Siqi Gao, Yao Wang, Tao Qi, Jingjing Wei, Ziying Hu, Jingtong Liu, Shuna Sun, Huihui Liu, Yongming Wang · 2023 · Molecular Therapy
  24. AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation
    Wei Dong Sun, Zhi Cheng, Jiuyu Wang, Jing Yang, Xueyan Li, Jinlong Wang, Minxuan Chen, Xiaoqi Yang, Gang Sheng, Jizhong Lou et al. · 2023 · Proceedings of the National Academy of Sciences
  25. Type II anti-CRISPR proteins as a new tool for synthetic biology
    Yadan Zhang, Mario Andrea Marchisio · 2020 · RNA Biology
  26. Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
    Christi T. Salisbury-Ruf, André Larochelle · 2021 · Journal of Clinical Medicine
  27. BAd-CRISPR: Inducible gene knockout in interscapular brown adipose tissue of adult mice
    Steven M. Romanelli, Kenneth T. Lewis, Akira Nishii, Alan C. Rupp, Ziru Li, Hiroyuki Mori, Rebecca L. Schill, Brian S. Learman, Christopher J. Rhodes, Ormond A. MacDougald · 2021 · Journal of Biological Chemistry
  28. Computational design of novel Cas9 PAM-interacting domains using evolution-based modelling and structural quality assessment
    Malbranke, Cyril, Rostain, William, Depardieu, Florence, Cocco, Simona, Monasson, Rémi, Bikard, David · 2023 · PLOS Computational Biology
  29. Decoding CRISPR–Cas PAM recognition with UniDesign
    Xiaoqiang Huang, Jun Zhou, Dongshan Yang, Jifeng Zhang, Xiaofeng Xia, Y. Eugene Chen, Jie Xu · 2023 · Briefings in Bioinformatics
  30. Crispr-Cas based biosensing: A fast-expanding molecular diagnostic tool
    Shweta Singh, Rinku Thakran, Ankur Kaushal, Reena Vohra Saini, Adesh Kumar Saini, Sonal Datta · 2024 · Microchemical Journal
  31. CRISPR/Cas in Grapevine Genome Editing: The Best Is Yet to Come
    Chong Ren, Mohamed Salaheldin Mokhtar Mohamed, Nuremanguli Aini, Yangfu Kuang, Zhenchang Liang · 2024 · Horticulturae
  32. Recent advances in CRISPR research
    Baohui Chen, Yuyu Niu, Haoyi Wang, Kejian Wang, Hui Yang, Wei Li · 2020 · Protein & Cell
  33. Efficient Homology-directed Repair with Circular ssDNA Donors
    Sukanya Iyer, Aamir Mir, Joel Vega‐Badillo, Benjamin P. Roscoe, Raed Ibraheim, Lihua Julie Zhu, Jooyoung Lee, Pengpeng Liu, Kevin Luk, Esther Mintzer et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?
    Ji‐Neng Lv, Haitao Xi, Xiujuan Lv, Yue Zhou, Jiahua Wang, Haoran Chen, Tong Yan, Jiang Jin, Junzhao Zhao, Feng Gu et al. · 2022 · Gene Therapy
  35. Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases
    Chengpeng Zhang, Jinchao Xu, Yikang Wu, Can Xu, Peng Xu · 2024 · Stem Cell Reviews and Reports
  36. Gene editing therapy for cardiovascular diseases
    Xinyu Wu, Jie Yang, Jiayao Zhang, Yuning Song · 2024 · MedComm
  37. CRISPR-based functional genomics tools in vertebrate models
    Gaurav K. Varshney, Shawn M. Burgess · 2025 · Experimental & Molecular Medicine
  38. Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
    Ainsley Mike Antao, Janardhan Keshav Karapurkar, Dong Ryul Lee, Kye-Seong Kim, Suresh Ramakrishna · 2020 · Computational and Structural Biotechnology Journal
  39. Engineering of a compact, high-fidelity EbCas12a variant that can be packaged with its crRNA into an all-in-one AAV vector delivery system
    Hongjian Wang, Jin Zhou, Jun Lei, Guosheng Mo, Yankang Wu, Huan Liu, Ziyan Pang, Mingkun Du, Zihao Zhou, Chonil Paek et al. · 2024 · PLoS Biology
  40. CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
    Seyed Mohammad Miri, Elham Tafsiri, William Chi Shing Cho, Amir Ghaemi · 2020 · Cancer Cell International
  41. Nickase fidelity drives EvolvR-mediated diversification in mammalian cells
    Juan E. Hurtado, Adam J. Schieferecke, Shakked O. Halperin, John Guan, Dylan Aidlen, David V. Schaffer, John E. Dueber · 2025 · Nature Communications
  42. TIGR-Tas and the Expanding Universe of RNA-Guided Genome Editing Systems: A New Era Beyond CRISPR-Cas
    Douglas Mark Ruden · 2025 · Genes
  43. Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress
    Zhuoying Ren, Jun Zhou, Dongshan Yang, Yanhong Guo, Jifeng Zhang, Jie Xu, Y Eugene Chen · 2026 · Cells
  44. Modular vector assembly enables rapid assessment of emerging CRISPR technologies
    Abby V. McGee, Yanjing V. Liu, Audrey L Griffith, Zsofia M Szegletes, Bronte Wen, Carolyn Kraus, Nathan W. Miller, Ryan J. Steger, Berta Escude Velasco, Justin A. Bosch et al. · 2024 · Cell Genomics
  45. Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson’s Disease
    Woong Choi, Seongkwang Cha, Kyoungmi Kim · 2024 · Cells
  46. Characterization of diverse Cas9 orthologs for genome and epigenome editing
    Gabriel L. Butterfield, Dahlia Rohm, Avery Roberts, Matthew A. Nethery, Anthony J. Rizzo, Daniel J. Morone, Lisa Garnier, Nahid Iglesias, Rodolphe Barrangou, Charles A. Gersbach · 2025 · Proceedings of the National Academy of Sciences
  47. In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers
    Yeeun Lee, Bookun Kim, Donghyun Lee, Seo Young Cheon, Seong Gi Lim, Younggwang Kim, Heebeom Koo · 2025 · Applied Physics Reviews
  48. CABE-RY: A PAM-flexible dual-mutation base editor for reliable modeling of multi-nucleotide variants
    Wanyu Tao, Qing Liu, Shisheng Huang, Xin Wang, Shiyuan Qu, Junfan Guo, Danfeng Ou, Guanglei Li, Yu Zhang, Xiangmin Xu et al. · 2021 · Molecular Therapy — Nucleic Acids
  49. Structural and Mechanistic Insight into CRISPR-Cas9 Inhibition by Anti-CRISPR Protein AcrIIC4Hpa
    Sungwon Hwang, Chuxi Pan, Bianca Garcı́a, Alan R. Davidson, Trevor F. Moraes, Karen L. Maxwell · 2021 · Journal of Molecular Biology
  50. Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models
    Platon Megagiannis, Rahul Suresh, Guy Armand Rouleau, Yang Zhou · 2022 · Advanced Drug Delivery Reviews
  51. The origin of unwanted editing byproducts in gene editing
    Jianhang Yin, Jiazhi Hu · 2022 · Acta Biochimica et Biophysica Sinica
  52. The history, use, and challenges of therapeutic somatic cell and germline gene editing
    Junghyun Ryu, Eli Y. Adashi, Jon D. Hennebold · 2023 · Fertility and Sterility
  53. Dynamic interplay between target search and recognition for a Type I CRISPR-Cas system
    Pierre Aldag, Marius Rutkauskas, Julene Madariaga-Marcos, Inga Songailienė, Tomas Šinkūnas, Felix E. Kemmerich, Dominik J. Kauert, Virginijus Šikšnys, Ralf Seidel · 2023 · Nature Communications
  54. Emerging trends in gene and cell therapy: CRISPR in DNA editing and beyond
    Ruijin Ji, Qiubing Chen, Ying Zhang · 2025 · Cell Reports Medicine
  55. Tetrazine-Ligated CRISPR sgRNAs for Efficient Genome Editing
    Zexiang Chen, Gitali Devi, Amena Arif, Phillip D. Zamore, Erik J. Sontheimer, Jonathan K. Watts · 2022 · ACS Chemical Biology
  56. Editing the Human Genome with CRISPR/Cas: A Review of its Molecular Basis, Current Clinical Applications, and Bioethical Implications
    Miguel Ahumada-Ayala, Regina Aguilar-López, Nicolai González-Stoylov, Esmeralda Palacio-Sosa, David Eduardo Cervantes-Barragán, Liliana Fernández‐Hernández · 2023 · Revista de investigaci�n Cl�nica
  57. Short cell-penetration peptide conjugated bioreducible polymer enhances gene editing of CRISPR system
    Xiaobo Wang, Chengyuan Cai, Weiqi Lv, Kechen Chen, Jiaxin Li, Kaitong Liao, Yanqun Zhang, Hongxin Huang, Ying Lin, Zhili Rong et al. · 2024 · Journal of Nanobiotechnology
  58. Anti-CRISPR Protein AcrIIC5 Inhibits CRISPR-Cas9 by Occupying the Target DNA Binding Pocket
    Sungwon Hwang, Megha K Shah, Bianca Garcı́a, Noor Hashem, Alan R. Davidson, Trevor F. Moraes, Karen L. Maxwell · 2023 · Journal of Molecular Biology
  59. CRISPR: a promising tool for lipid physiology and therapeutics
    Mia N. Furgurson, William R. Lagor · 2019 · Current Opinion in Lipidology
  60. A redox switch regulates the assembly and anti-CRISPR activity of AcrIIC1
    Yanan Zhao, Jiaojiao Hu, Shanshan Yang, Jing Zhong, Jianping Liu, Shuo Wang, Yuzhuo Jiao, Fang Jiang, Ruiyang Zhai, Bingnan Ren et al. · 2022 · Nature Communications
  61. Improvements in the genetic editing technologies: CRISPR-Cas and beyond
    Gerard Mingarro, Marcel·lí del Olmo · 2022 · Gene
  62. Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope
    Ding Zhao, Xun Gao, Jiale Zhou, Jinze Li, Yuqiang Qian, Di Wang, Wenchao Niu, Tao Zhang, Mingyang Hu, Haoyang Xiong et al. · 2023 · BMC Biology
  63. Characterization of the genome editing with miniature DNA nucleases TnpB and IscB in Escherichia coli strains
    Hongjie Tang, Jie Gao, Hengyi Wang, Mingjun Sun, Suyi Zhang, Chuan Song, Qi Li · 2025 · Communications Biology
  64. Expanding the genome editing toolbox ofSaccharomyces cerevisiaewith the endonucleaseErCas12a
    Nicole Xanthe Bennis, Jonah P Anderson, Siebe M C Kok, Jean-Marc G Daran · 2023 · FEMS Yeast Research
  65. Direct Injection of Recombinant AAV-Containing Solution into the Oviductal Lumen of Pregnant Mice Caused In Situ Infection of Both Preimplantation Embryos and Oviductal Epithelium
    Masahiro Sato, Nami Sato-Yamamoto, Ai Wakita, Misako Haraguchi, Manabu Shimonishi, Hiroyuki Okuno · 2022 · International Journal of Molecular Sciences
  66. Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability
    Lisa M. Alexander, Daniela S. Aliaga Goltsman, Jason Liu, Jyun‐Liang Lin, Morayma M. Temoche-Diaz, Sarah M. Laperriere, Andreas Neerincx, Christien Bednarski, Philipp Knyphausen, André Cohnen et al. · 2023 · The CRISPR Journal
  67. Structure and evolution-guided design of minimal RNA-guided nucleases
    Petr Skopintsev, Isabel Esain-Garcia, Evan C. DeTurk, Peter H. Yoon, Zehan Zhou, Trevor J. Weiss, Maris Kamalu, Ajit Chamraj, Kenneth J. Loi, Conner J. Langeberg et al. · 2026 · Science
  68. Therapeutic gene editing is here, can regulations keep up?
    Soumya Kannan, Devora Najjar · 2020 · MIT Science Policy Review
  69. Treating Cardiovascular Disease with Liver Genome Engineering
    Ayrea E. Hurley, William R. Lagor · 2022 · Current Atherosclerosis Reports
  70. A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors
    Zexiang Chen, Suet‐Yan Kwan, Aamir Mir, Max D. Hazeltine, Minwook Shin, Shun‐Qing Liang, Io Long Chan, Karen L. Kelly, Krishna Sumanth Ghanta, Nicholas Gaston et al. · 2023 · The CRISPR Journal
  71. Engineering of a high-fidelity Cas12a nuclease variant capable of allele-specific editing
    Jingjing Wei, Jingtong Liu, Ziwen Wang, Yuan Yang, Yuwen Tian, Shengzhou Wang, Bao‐Qing Gao, Song Gao, Yang Li, Junnan Tang et al. · 2024 · PLoS Biology
  72. CRISPR technology in human diseases
    Qiang Feng, Qirong Li, Hengzong Zhou, Zhan Wang, Chao Lin, Ziping Jiang, Tianjia Liu, Dongxu Wang · 2024 · MedComm
  73. Parallel engineering and activity profiling of a base editor system
    John H.C. Fong, Hoi Yee Chu, Peng Zhou, Alan S.L. Wong · 2023 · Cell Systems
  74. Nme2Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset
    Sihui Hu, Yuxi Chen, Dongchun Xie, Kan Xu, Yunzhao Fu, Wei Chi, Haiying Liu, Junjiu Huang · 2023 · Clinical and Translational Medicine
  75. Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing
    Irene Carrozzo, Giulia Maule, Carmelo Gentile, Alessandro Umbach, Matteo Ciciani, Daniela Guidone, Martina De Santis, Gianluca Petris, Luis J. V. Galietta, Daniele Arosio et al. · 2025 · Molecular Therapy
  76. Discovery and engineering of ChCas12b for precise genome editing
    Jingjing Wei, Jingtong Liu, Yuwen Tian, Ziwen Wang, Linghui Hou, Yuan Yang, Chen Tao, Miaomiao Li, Bao‐Qing Gao, Huanyu Zhou et al. · 2024 · 中国科学通报:英文版
  77. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective
    Nazma F. Ilahibaks, Maike J. Hulsbos, Zhiyong Lei, Pieter Vader, Joost P. G. Sluijter · 2022 · Advances in experimental medicine and biology
  78. Nucleic Acid Therapeutics
    Jonathan K. Watts · 2022 · Royal Society of Chemistry eBooks
  79. TIGER: Single-step in vivo genome editing in a non-traditional rodent
    Sha Li, Sarah A. Mereby, Megan Rothstein, Matthew R. Johnson, Benjamin J. Brack, Ricardo Mallarino · 2023 · Cell Reports
  80. Versatile and efficient genome editing with Neisseria cinerea Cas9
    Zhiquan Liu, Siyu Chen, Wanhua Xie, Hao Yu, Liangxue Lai, Zhanjun Li · 2022 · Communications Biology
  81. General and robust sample preparation strategies for cryo-EM studies of CRISPR-Cas9 and Cas12 enzymes
    Satoshi N. Omura, Osamu Nureki · 2025 · Methods in enzymology on CD-ROM/Methods in enzymology
  82. From IscB to Cas9: Engineering and advances in the next generation of miniature gene editing tools
    Changli Zhou, Sisi Zhu, Chengjian Luo, Wenju Wang, Hui-Qin Fan, Yuan Gao, Xinde Xu, Qiuyan Wang, You Yu, Tian Xie · 2025 · Biotechnology Advances
  83. Recent advances in the use of CRISPR/Cas for understanding the early development of molecular gaps in glial cells
    Carla P. Barragán-Álvarez, José Miguel Flores-Fernández, Oscar R. Hernández‐Pérez, Daniela Ávila‐González, Néstor Fabián Díaz, Eduardo Padilla‐Camberos, Octavio Dublán‐García, Leobardo Manuel Gómez‐Oliván, Nestor Emmanuel Diaz-Martinez · 2022 · Frontiers in Cell and Developmental Biology
  84. Advancing CRISPR base editing technology through innovative strategies and ideas
    Xiongwei Fan, Yang Lei, Liren Wang, Xiushan Wu, Dali Li · 2024 · Science China Life Sciences
  85. The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss
    Junhao Wu, Yong Tao, Di Deng, Zhaoli Meng, Yu Zhao · 2023 · Cell & Bioscience
  86. Advances in CRISPR/Cas-Based Strategies on Zoonosis
    Yi Zhang, Qifeng Peng, Renjun Zhang, Chao Li, Quangang Xu, Luming Xia, Youming Wang, Ping Liu, Hong Pan · 2023 · Transboundary and Emerging Diseases
  87. Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo
    Susu Wu, Liping Li, Min Li, Shiyu Sun, Yuting Zhao, Xiaowen Xue, Feiyu Chen, Jingli Zhong, Junfan Guo, Qianhui Qu et al. · 2022 · Frontiers in Cell and Developmental Biology
  88. A Minimal and Portable CRISPR Platform Based on Bifidobacterial Cas9 Enables Genome Editing in E. coli Nissle 1917
    Qibing Liu, Yan Huang, Ran Zhou, Honghao Ding, Qingqing Nie, Xiaoyuan Gong, Ting Zuo, Shuai Wang, Yunxiang Liang, Yingjun Li · 2026 · ACS Synthetic Biology
  89. Engineering of SauriCas9 with enhanced specificity
    Xiaoqi Zhang, Chen Tao, Miaomiao Li, Sufang Zhang, Puping Liang, Yan Hua Huang, Huihui Liu, Yongming Wang · 2025 · Molecular Therapy — Nucleic Acids
  90. A compact base editor rescues AATD-associated liver and lung disease in mouse models
    Jenny Gao, Nathan Bamidele, Debora Pires-Ferreira, Chunwei Zheng, April Destefano, Haoyang Cheng, Qiushi Tang, Yueying Cao, Jun Xie, Guangping Gao et al. · 2025 · Molecular Therapy
  91. Genome Editing in Dyslipidemia and Atherosclerosis
    Zhifen Chen, Constanze Lehertshuber, Heribert Schunkert · 2022 · Advances in experimental medicine and biology
  92. Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals
    Milan M. Medd, Qi Cao · 2024 · Biomedicines
  93. Identification of the EH CRISPR‐Cas9 system on a metagenome and its application to genome engineering
    Esquerra‐Ruvira, Belen, Baquedano, Ignacio, Ruiz, Raul, Fernandez, Almudena, Montoliu, Lluis, Mojica, Francisco J. M. · 2023 · Microbial Biotechnology
  94. Engineered Staphylococcus auricularis Cas9 with high‐fidelity
    Nan Wei, Lu Shang, Jing Liu, Mi Wang, Yingchun Liu, Chuangang Zhu, Chenzhong Fei, Lifang Zhang, Fayu Yang, Feng Gu · 2023 · The FASEB Journal
  95. Molecular Basis and Genome Editing Applications of a Compact Eubacterium ventriosum CRISPR-Cas9 System
    Na Tang, Zhaowei Wu, Yan Gao, Weizhong Chen, Zixiao Wang, Mengjiao Su, Wenxin Ji, Quanjiang Ji · 2023 · ACS Synthetic Biology
  96. Orthogonal CRISPR-Cas tools for genome editing, inhibition, and CRISPR recording in zebrafish embryos
    Paige R. Takasugi, Shengzhou Wang, Kimberly T. Truong, Evan P. Drage, Sahar N. Kanishka, Marissa A. Higbee, Nathan Bamidele, Ogooluwa Ojelabi, Erik J. Sontheimer, James A. Gagnon · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Enlarged DNA unwinding by Nme2Cas9 permits a broadened base editing window beyond the protospacer
    Ziting Chen, Xiangyang Li, Qian Zhang, Wenjun Sun, Xiaoxuan Song, Xia Zhang, Xingxu Huang, Bo Sun · 2023 · Science China Life Sciences
  98. Characterization of CoCas9 nuclease from Capnocytophaga ochracea
    A. Vasileva, Polina Selkova, Alexander S. Arseniev, Marina Abramova, Nataliia Shcheglova, Olga S. Musharova, Игорь Викторович Мизгирев, Т. О. Артамонова, Mikhail A. Khodorkovskii, Konstantin Severinov et al. · 2023 · RNA Biology
  99. Characterization of NiCas12b for In Vivo Genome Editing
    Yunqian Zhang, Jingjing Wei, Hongyan Wang, Yongming Wang · 2024 · Advanced Science
  100. Evolution of the CRISPR-Cas9 defence system in Mycoplasma gallisepticum following colonization of a novel bird host
    Thomas Ipoutcha, Ιason Τsarmpopoulos, Géraldine Gourgues, Vincent Baby, Paul Dubos, Geoffrey E. Hill, Yonathan Arfi, Carole Lartigue, Patricia Thébault, Camille Bonneaud et al. · 2024 · Microbial Genomics